Female Health Company (NASDAQ:FHCO) has been able to sustain quality economics while benefiting from first mover advantage. They have garnered a near absolute monopoly of female condoms in the public health sector, who's goal is the prevention of HIV worldwide. New female condom manufacturers are starting to gain qualification as viable alternatives to FHCO's only condom FC2 and the Gates Foundation has announced their support to fund the creation of a superior condom that would promote more usage. The company has virtually no analyst coverage, the market does not like that FHCO's revenues are lumpy and recent selling indicates that the market believes FHCO's wide moat is in danger. Mr. Market expects slower growth and lower profitability. We...
|FREE||SA PRO MEMBERS|
|IDEA GENERATOR||X||Exclusive access to 10 PRO ideas every day|
|INVESTING IDEAS LIBRARY||X||Exclusive access to PRO library of more than 15,000 ideas|
|SECTOR EXPERT NETWORK||X||Exclusive access to all sector experts for direct consultation|
|PERFORMANCE TRACKING||X||Track performance of all PRO stock ideas|
|PROFESSIONAL TOOLS||X||Professional Idea Filters to zero-in based on industry, market cap and more|